Pediatrix Medical Price Target Raised to $10.00/Share From $8.00 by Truist Securities
Pediatrix Medical Group Analyst Ratings
Truist Financial Maintains Pediatrix Medical(MD.US) With Hold Rating, Announces Target Price $10
Truist Adjusts Price Target on Pediatrix Medical Group to $10 From $8, Maintains Hold Rating
Pediatrix Medical Group: Cautious Hold Rating Amidst Financial Growth and Restructuring
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bio-Techne (TECH), Pediatrix Medical Group (MD) and Arcus Biosciences (RCUS)
UBS Adjusts Pediatrix Medical Group Price Target to $10.50 From $9, Maintains Neutral Rating
Pediatrix Medical Group Analyst Ratings
Pediatrix Medical Group: Strong EBITDA Amidst Strategic Shifts, Yet Uncertainties Prompt Hold Rating
Deutsche Bank Raises Pediatrix Medical Group Price Target to $9 From $8, Maintains Hold Rating
Pediatrix Medical Group (MD) Gets a Hold From Truist Financial
Truist Securities Cuts Price Target on Pediatrix Medical to $8 From $10, Maintains Hold Rating
Pediatrix Medical Group Analyst Ratings
Truist Securities Maintains Hold on Pediatrix Medical Group, Lowers Price Target to $8
Pediatrix Medical Group Analyst Ratings
Deutsche Bank Upgrades Pediatrix Medical Group to Hold From Sell, $8 Price Target
Pediatrix Medical Group Analyst Ratings
Maintaining Hold: Assessing Pediatrix Medical Group's Rebound Amidst Restructuring and Rising Costs
Pediatrix Medical Group: Hold Rating Amidst Positive Birth Trends and Revenue Cycle Risks
Maintaining Hold on Pediatrix Medical Group Amidst Birth Rate Trends and Financial Caution